Queen's University Belfast and Fusion Antibodies

Abstract

To develop new innovative processes to create a novel platform technology for the generation and maturation of fully human antibodies that can be rapidly progressed by clients into clinical development.

Lead Participant

Project Cost

Grant Offer

Queen's University of Belfast, United Kingdom £232,264 £ 155,617

Publications

10 25 50